DNA containing bioactive CpG motifs promote angiogenesis

被引:7
作者
Klinman, DM
Zheng, M
Gierynska, M
Rouse, BT
机构
[1] US FDA, Sect Retroviral Immunol, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[2] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA
关键词
D O I
10.1358/dnp.2002.15.6.840034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Unmethylated CpG motifs exist at high frequency in the genomes of many bacteria and viruses, including the herpes simplex virus (HSV). These motifs are intrinsically bioactive, stimulating cells of both the immune and central nervous systems. Researchers explored the notion that DNA containing CpG motifs could mediate additional effects in vivo, focusing on whether CpG DNA could directly or indirectly promote the formation of new blood vessels (angiogenesis). They found that both purified HSV DNA and synthetic oligodeoxynucleotides (ODN) containing CpG motifs stimulated new blood vessel formation. This effect was associated with the production of vascular endothelial growth factor (VEGF) and was prevented by the co-administration of anti-VEGF antibodies Results of the study suggest that bioactive CpG motifs induce the production of VEGF, thereby promoting angiogenesis, and raise the possibility that CpG ODN may be of benefit in clinical states that require revascularization. (C) 2002 Prous Science All rights reserved.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 27 条
[11]   Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs [J].
Krieg, AM ;
Wu, T ;
Weeratna, R ;
Efler, SM ;
Love-Homan, L ;
Yang, L ;
Yi, AK ;
Short, D ;
Davis, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12631-12636
[12]  
Krieg AM, 2001, CURR OPIN MOL THER, V3, P15
[13]   CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation [J].
Lenert, P ;
Stunz, L ;
Yi, AK ;
Krieg, AM ;
Ashman, RF .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2001, 11 (04) :247-256
[14]   Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines [J].
Lipford, GB ;
Sparwasser, T ;
Bauer, M ;
Zimmermann, S ;
Koch, ES ;
Heeg, K ;
Wagner, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3420-3426
[15]   CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants [J].
Lipford, GB ;
Bauer, M ;
Blank, C ;
Reiter, R ;
Wagner, H ;
Heeg, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2340-2344
[16]   Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants [J].
McCluskie, MJ ;
Davis, HL .
VACCINE, 2000, 19 (4-5) :413-422
[17]  
Razin A, 1981, Prog Nucleic Acid Res Mol Biol, V25, P33, DOI 10.1016/S0079-6603(08)60482-1
[18]   Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants [J].
Roman, M ;
MartinOrozco, E ;
Goodman, S ;
Nguyen, MD ;
Sato, Y ;
Ronaghy, A ;
Kornbluth, RS ;
Richman, DD ;
Carson, DA ;
Raz, E .
NATURE MEDICINE, 1997, 3 (08) :849-854
[19]  
Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO
[20]  
2-8